Alvaro
Lassaletta Atienza
Consultor Médico
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (6)
2023
-
Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908
Neuro-Oncology, Vol. 25, Núm. 8, pp. 1530-1545
-
Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation Sparing Approaches: An International Cohort Study
Journal of Clinical Oncology, Vol. 41, Núm. 10, pp. 1921-1932
2020
-
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
Cancer Cell, Vol. 37, Núm. 4, pp. 569-583.e5
2019
-
Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition
JCO Precision Oncology
2017
-
Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy
Annals of Hematology, Vol. 96, Núm. 9, pp. 1449-1456
2016
-
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis
Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477